Open AccessMinimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
Author(s) -
Petra Pokorná,
Giannoula Klement,
Alzbeta Vasikova,
Veronika Kanderová,
Marta Ježová,
Kristýosková,
Peter Múdrý,
Michal Kýr,
Tomáš Merta,
Viera Bajčiová,
Zdenka Křenová,
Hana Pálová,
Dalibor Valík,
Lenka Zdražilová Dubská,
Ondřej Slabý,
Jaroslav Štěrba
Publication year - 2022
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
ISSN - 2473-4284
DOI - 10.1200/po.21.00525
Subject(s) - dosing , medicine , minimal residual disease , anaplastic large cell lymphoma , lymphoma , cancer , leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom